The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...

While conducting the study, the researchers tracked data from more than 10,000 patients who presented with type 2 diabetes, ...

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

A new study reveals that diabetes significantly accelerates the emergence and spread of antibiotic-resistant Staphylococcus ...

RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

Attorney General Kwame Raoul is leading a bipartisan coalition of 37 states and territories urging the Food and Drug ...

The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...